---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/43900857.md"
description: "Many investors are tracking the odds shifts for the Clarity Act on Polymarket, which have swung from 15% to 30% and back down to 19% over the past two days, reflecting a tense tug-of-war between the two parties.It's important to note that the 19% or 30% odds on Polymarket specifically refer to the likelihood of the bill being enacted by 2026. The Sept. 15 vote merely determines whether the bill enters the Senate review agenda. With midterm elections this year and the House adjourning early in late September, even if the Sept. 15 vote passes, the window for subsequent legislative action remains tight, keeping Polymarket odds low.The current focus is on the Sept. 15 vote itself. I believe the probability of passage here is far higher than the 19% implied by Polymarket. A likely outcome is a bipartisan compromise: passing the vote to uphold procedural norms while continuing to haggle during later legislative stages. This means significant hurdles remain for 2026 enactment—so the 19% figure might still be accurate—but it doesn't change the fact that the Sept. 15 vote has a ~40–50% chance of passing.$Strategy(MSTR.US)$Coinbase(COIN.US)$Circle(CRCL.US)$BitMine Immersion Tech(BMNR.US)"
datetime: "2026-09-15T03:26:21.000Z"
locales:
  - [en](https://longbridge.com/en/topics/43900857.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/43900857.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/43900857.md)
author: "[lyhalfway](https://longbridge.com/en/profiles/3372973.md)"
generator: "portal-rs"
---

# Many investors are tracking the odds shifts for th…


### Related Stocks

- [MSTR.US](https://longbridge.com/en/quote/MSTR.US.md)
- [STRC.US](https://longbridge.com/en/quote/STRC.US.md)
- [STRD.US](https://longbridge.com/en/quote/STRD.US.md)
- [STRF.US](https://longbridge.com/en/quote/STRF.US.md)
- [STRK.US](https://longbridge.com/en/quote/STRK.US.md)
- [COIN.US](https://longbridge.com/en/quote/COIN.US.md)
- [CRCL.US](https://longbridge.com/en/quote/CRCL.US.md)
- [BMNR.US](https://longbridge.com/en/quote/BMNR.US.md)
- [BMNP.US](https://longbridge.com/en/quote/BMNP.US.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**